Abstract
Regularly alternating periods of light and darkness, such as normally occur with the rising and the setting of the sun, are essential for the maintenance of undisturbed circadian rhythms in all organisms including humans. The light–dark environment, as detected by specialized photoreceptors in the retinas, impacts the endogenous circadian clock in the anterior hypothalamus, the suprachiasmatic nuclei. These nuclei, via both neural and humoral signals, communicate with cells throughout the organism to establish regular circadian rhythms. The introduction of artificial sources of light roughly 150 years ago has significantly undermined the naturally occurring light–dark environment and, likewise, has disturbed circadian rhythms since light is now available at unusual times, i.e., at night. Light at night is known to cause circadian disruption and melatonin suppression. Of many potentially pathophysiological consequences of these artificial light-mediated changes, female breast cancer has become of major interest. Additionally, however, there is currently data suggesting that not only breast cancer, but cancer in general, cardiovascular diseases, insomnia, metabolic syndrome, and affective and cognitive disorders may be aggravated by the increased exposure to light at night, which is inevitable in well-developed societies that have undergone extensive electrification.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Introduction
Clearly, circadian rhythms are so commonplace in animal and human physiology that, a priori, we must assume they are relevant to optimal function. Indeed, this fact is becoming progressively more apparent as scientists examine 24-h variations in the physiology of organisms, organs, cells and cellular organelles [1–3]. With an estimated 10–20 % of the genes in each cell under control of the central oscillator, the suprachiasmatic nuclei (SCN) in the anterior diencephalon, it is easy to envisage that disturbances of these clock mechanisms, particularly when repeated or chronic, may well lead to pathologies.
While the SCN exhibits an intrinsic rhythm of approximately 24 h, corresponding roughly to the normal environment light–dark cycle, it is not precisely of 24-h duration. Thus, light information detected by specialized ganglion cells (the intrinsic photoreceptive ganglion cells, i.e., ipRGC) [4–6] in the retinas and the transfer of this information via the retinohypothalamic tract to the SCN, serves as an important and critical Zeitgeber for the central oscillator. This, in turn, influences the circadian physiology of all peripheral oscillators. Thus, whereas cells in organs throughout the body are incapable of direct photoreception, they do receive information as to whether it is day or night from the central clock and they adjust their functions accordingly.
The means by which the SCN conveys circadian information to the peripheral cellular oscillators includes both neural and humoral messages. One important humoral message is the melatonin signal from the pineal gland [7]. Due to information detected by the ipRGC of the retina and relayed through the SCN, the pinealocytes are apprised of the prevailing light–dark environment. During the day messages from the ipRGC render the SCN dormant relative to its ability to activate the pineal gland. During darkness, the SCN, via a circuitous neural route that involves portions of the central and peripheral sympathetic nervous system, stimulates the pinealocytes to synthesize and quickly release the chemical mediator, melatonin [7, 8]. This agent then circulates throughout the body and informs, perhaps every cell, of the prevailing photoperiodic environment so that functional adjustments can be made [9, 10].
Considering that the circadian system is composed by multiple body clocks, it is important to note that, aside from light–dark influences to the SCN, other peripheral oscillators are very sensitive to non-photic synchronizers such as feeding time, scheduled exercise, sleep time and social contacts. This complexity, together with the weakness of exposure to synchronizers in developed countries, makes the circadian system prone to suffer from chronodisruption (CD).
What Causes Chronodisruption?
Circadian disruption or CD is defined as a relevant disturbance of the internal temporal order of physiological and behavioral circadian rhythms. It is also a breakdown of the normal phase relationship between the internal circadian rhythms and 24-h environmental cycles. In our modern society, CD may be common in several conditions such as jet lag, shift work, light at night, or social jet lag [11]. In addition clock gene polymorphisms and aging may have also chronodisruptive effects. Thus, CD can be induced by any impairment of the inputs, oscillators and outputs (Fig. 4.1).
Inadequate Inputs
Importance of a Regular Light–Dark Cycle
Since the light–dark (LD) cycle regulates the 24-h melatonin synthesis/secretion rhythm, it is obvious that perturbations of this regularly recurring cycle would likewise alter the melatonin message leading to misinformation being sent to the peripheral cellular clocks. Throughout eons of evolution, disturbances of the LD environment did not occur since the SCN was regulated and the melatonin rhythm was determined exclusively by the rising and the setting of the sun. Only after the invention of the artificial light source by Thomas Alva Edison in 1879 were humans capable of imposing the LD cycle they desired. This was a major turning point for circadian biology since it allowed humans to inadvertently alter an important basic system, the circadian system, and to also perturb the melatonin rhythm. These perturbations in the melatonin rhythm could not be ignored by the peripheral cellular oscillators and they then were required to make unexpected adjustments to their physiology at unusual times. Not surprisingly, these atypical changes of a very basic rhythm, which had been unvarying throughout evolution, would be expected to cause abnormal physiology and perhaps pathologies [2, 12, 13].
Already several decades ago it was shown that the exposure of animals or humans to light at night (LAN) depresses elevated nighttime melatonin levels, i.e., it changes the melatonin message [14–18]. Since these early discoveries in this field, numerous subsequent investigations have more precisely defined the mechanisms by which LAN inhibits the synthesis and discharge of melatonin, thereby destroying its regular circulating rhythm [6, 7].
LAN has a number of unnatural effects on the circadian system and on pineal melatonin production. In the well-developed countries of the world where electricity is readily available, it is usual to turn on manufactured lights at the time the sunsets. Likewise, when humans awaken in the morning and it is still dark, their first activity is to turn on a light. What this obviously means is that humans are no longer allowing the natural LD cycle to regulate their SCN and the production of melatonin; rather they unwittingly manipulate these processes with the misuse of artificial light.
In the situation summarized above, where light is extended into the normal period of darkness and light exposure also occurs in the morning before sunrise, the SCN must adjust its signaling processes accordingly; one result of this imposed artificial light is a shortening of the nightly duration of melatonin production by the pineal gland [19]. Thus, in highly industrialized societies, humans have become relatively melatonin deficient since they truncate the normal period of darkness and, thereby, the duration of elevated melatonin.
In general, the only time humans are in darkness is when they sleep. Thus, depending on their nightly sleep duration, which is also becoming progressively shorter in developed societies [20, 21], the total amount of melatonin produced may be reduced by 50 % or more relative to what would have been generated had they been exposed to the natural LD cycle. Given the multiple beneficial actions of melatonin [22–25], a 50 % loss of the total amount of melatonin nightly would be expected to have consequences, including negative effects, i.e., pathologies, [26–28].
A second danger of the availability of manufactured light is the ability of humans to acutely expose themselves to light during the normal dark period. During the night, the ipRGC detect the light that is actively imposed and they signal the SCN that it is “day,” when in fact it is night. The SCN, in turn, communicates with organs throughout the organism, including the pineal gland, and provides them with misinformation. Even though the information received is inappropriate for the time, molecular and physiological adjustments are made by peripheral organs consistent with the normal daytime period. Thus, the physiology of these cells is no longer in synchrony with the normal LD cycle. This incoordination results in chronodisruption [10], a situation which could certainly lead to pathophysiologies [2, 13, 15, 29].
One conspicuous result of acute bright light exposure at night is a rapid plummeting of circulating melatonin levels [14, 17]. This abnormal drop in blood melatonin is also “read” by numerous cells throughout the body and, since melatonin values are normally low only during the day, again the peripheral organs are misled as to time. Such severe perturbations and dyssynchrony between organ physiology and the prevailing LD environment would not surprisingly be expected to cause functional casualties.
There is one other hazard associated with the massive electrification that has occurred in many places in the world. In cities especially, LAN has become unavoidable because of light pollution. Photographs of America, Europe, Japan, etc., taken from outer space at night reveals the degree of light pollution that has taken place in recent decades and predictably will become progressively worse in the years ahead. What this means is that it is becoming more difficult for humans to avoid LAN and, as a result, we may be becoming progressively more chronodisrupted. Moreover, in the sleeping environment it is sometimes difficult to evade transpass light, i.e., light that is out of the control of the person being exposed. The degree to which light pollution, transpass light, etc., impacts circadian physiology and pineal melatonin production has not been well defined, but deserves close scrutiny. Finally, parents should be discouraged from permitting their children to sleep in a lit room because they are intimidated by darkness. In the case of children, LAN may be particularly harmful since this is the age at which their circadian system is maturing. Presumably, any pathologies that may develop as a result of chronic chronodisruption may appear years or even decades after the disturbances have occurred.
Consequences of disturbing the light–dark cycle, as already mentioned, the extension of the light phase into the normal period of darkness and likewise truncating the night by artificial light exposure in the morning, limits the total amount of melatonin that would normally be produced in a seasonally appropriate LD cycle. While these maneuvers reduce the total quantity of melatonin produced, they do not eradicate its basic circadian rhythm [19]. The reduction in the total amount of melatonin produced during a 24-h period by itself may, however, be consequential in terms of at least one pathophysiological state, i.e., cancer [23, 30–32].
Sleep Deprivation
In addition to limiting the quantity of melatonin generated nightly, the excessive use of light in the evening and in the morning is usually associated with abbreviated nightly sleep periods. Adequate sleep is also essential for optimal health [33]. The daily sleep interval is becoming shorter in a number of countries. For example, in the USA the nightly sleep period has been dropping over the last half century. In the 1960s, the duration of sleep by US citizens was on the order of 8 h; the current best measures indicate that this is currently about 6.5 h [34]. Since sleep duration is usually associated with dark exposure, there has been a corresponding drop in melatonin production in the last 50 years as well. In addition to the obvious reduction in work efficiency that accompanies sleepiness, the health consequences of insufficient rest combined with reduced melatonin are likely also substantial [15, 29].
Virtually all studies that have examined a possible association between nightly sleep duration and cancer, most often female breast cancer, have found a relationship, i.e., short sleep correlated with elevated cancer incidence [35–37]. Each of these workers also noted that reduced sleep likely also meant limited elevated melatonin levels every night. Considering the multiple means by which this indole inhibits tumors, its reduction would likely be a contributing factor to the higher breast cancer incidence [30, 38, 39].
Feeding Time
Rhythmic feeding appears to be the major synchronizer for peripheral oscillators. Thus, unusual feeding time can produce CD by inducing internal desynchronization through decoupling of peripheral oscillators from the SCN. For example, it has been described that clock gene expression in the liver can synchronize to scheduled feeding in 2 days while SCN remains locked to LD cycle [40]. This differential synchronization induced by abnormal feeding habits could produce unhealthy consequences also in humans. Thus, when nocturnal (characterized by late awakening, omitting breakfast and late dinner) and diurnal (early awakening and early dinner) lifestyles were compared among healthy young people, glucose tolerance and insulin response were found to be well regulated in the diurnal group, while sustained hyperglycemia and hypoglycemia in the morning were observed in the case of nocturnal lifestyle [41] In addition, plasma levels of melatonin and leptin were reduced during the night in the nocturnal lifestyle group.
Different laboratory experiments are inducing internal desynchrony in human by forced desynchronization protocols placing subjects with sleep–wake and feeding rhythms on a 28-h daily routine for several days [42]. Interestingly, under such artificial conditions, body temperature, which is under the SCN control, remains near 24 h cycle, whereas rhythmicity in different metabolic hormones such as leptin and insulin, adhered to the imposed 28-h behavioral cycle of sleep and food intake. This misalignment induces a suppression of plasma leptin, increase in glycemia, and hypertension. Therefore, unusual feeding times are likely an overlooked risk factor to the health in modern societies.
Impaired Pacemakers
Jet lag and rotating shift-work are two well documented factors inducing CD. These two factors share a common mechanism in the CD generation involving the differential rates of synchronization of biological variables. This may be the result of the different contribution of SCN and peripheral oscillators to the generation of biological rhythms in different variables. For example, following a 6-h phase delay, the acrophase of ACTH and cortisol rhythms need up to 7 days to resynchronize, while it takes only 3 days in the case of sleep–wake cycle. Thus, during these days each function shifts at a different rate and the organism is suboptimally organized to efficiently accomplish its functions [11]. This condition is even more serious in the case of shift-workers because its chronic character.
CD can also be produced by the impairment of the molecular machinery of the circadian clock; however, discerning the relative influence of disrupted circadian rhythms induced by clock gene alteration from the potential pleiotropic effects of core clock gene inducing pathological process will therefore be a challenge [43]. Alterations in some clock genes have been associated with specific diseases such as premature aging, cancer, and obesity among others.
Mice without Bmal1 gene are arrhythmic and are subjected to premature aging and the mean lifespan of these animals is of 37 weeks as compared with 120 weeks for wild-type animals. In addition, Bmal1-knockout mice exhibit sarcopenia, vision problems, and altered lymphocytopenia [44].
Mutations in Per2 gene, another core clock gene, increases the susceptibility of mice to develop spontaneous and irradiation-induced tumors, through the stimulation of the protooncogene c-myc and repression of the oncostatic p53 gene [45]. Another well known example of clock gene induced pathology is obesity and metabolic syndrome associated with impaired Clock gene expression. CLOCK protein is a key factor involved in the synchronization of metabolic processes with the environment and in the control of mammalian energy balance. As expected, Clock-mutant mice show reduced or abolished rhythms in food intake and metabolic rate, but, in addition these animals are obese, exhibit adipocyte hypertrophy, hepatic steatosis, and alteration in leptin blood levels [29].
Outputs
The third element which can cause CD are the alteration of the outputs of the central pacemaker which act as internal coupling synchronizing signal to maintain the internal temporal order among different rhythmic functions. Impairment of the melatonin rhythm is the best known output factor mediating CD, as has been mentioned at the beginning of this chapter.
Pathological Consequences of CD
In the last decade, the effect of CD on human health has become an important issue. Indeed nowadays we certainly know that several chronic diseases, which widely affect our society, are influenced by chronobiological components (Fig. 4.1).
Chronodisruption and Cancer
Experimentally, it is well documented that unusual changes in the LD cycle that cause chronodisruption lead to accelerated growth of cancers. Using mice bearing transplanted Glasgow osteosarcomas, Filipski et al. [46] noted that these tumors grew more rapidly when the mice were exposed to a simulated eastward flight that caused an 8-h phase advance every 2 days. This recurring unusual 8-h photoperiodic change, which would duplicate a flight from the mid-USA to central Europe caused chronic circadian disruption relative to mice maintained in a stable photoperiodic cycle.
In the study by Filipski and colleagues [46], in addition to the mice suffering circadian misalignment, they very possibly exhibited an abnormal or more likely, no nighttime rise in melatonin production and secretion. Since the actual levels of melatonin were not measured in these animals, it remains undetermined if melatonin suppression was a factor in the more rapid tumor growth. It seems likely, however, that several changes, i.e., circadian disruption, melatonin suppression, sleep deprivation, etc., conspired to promote the accelerated growth of the transplanted osteosarcoma cells.
That electrolytic destruction of the biological clock, i.e., the SCN, and the resultant circadian disruption, stimulates cancer progression was confirmed in a study performed by the same group. In this case, Filipski and Li [47] electrolytically lesioned the SCN of mice bearing implanted tumors. This destructive procedure caused the cancers to grow more rapidly. While loss of the SCN would certainly destroy and/or severely compromise the circadian rhythms of all organs, the lesions also surely demolished the cyclic production and release of pineal melatonin; therefore, the mice were deficient in this cancer-inhibiting indoleamine. Because of the multiple negative actions resulting from lesions of the SCN, the basis of the accelerated progression of the cancer in the mice lacking their central clock remains undetermined.
Other studies also point to a role of the circadian network and chronodisruption in the acceleration of cancer growth [48]. The expression of the Per2 gene is a critical factor in circadian organization. In mice genetically devoid of the Per2 gene, the typical circadian cycle of 24–25 h becomes shortened to less than 24 h. A high percentage of the mice with this circadian malady spontaneously develop lymphomas by the time they are 16 months of age. Normally, these tumors in intact mice do not appear until the animals are beyond 20 months of age. The findings of Fu and coworkers [45] also support a role for the involvement of circadian genes in cancer cell proliferation.
Similar to that described in experimental animals, several evidences link CD and cancer also in human. Thus, for at least two decades, epidemiologists have been interested in the association between LAN, along with the associated changes in the underlying physiology, and the elevated incidence of breast cancer risk. The initial reports claimed that a higher frequency of breast cancer was apparent in attendants who routinely worked as airline hostesses on long flights over multiple time zones [49, 50] and in women who commonly performed night shift work over long periods of time [51, 52]. The workers most commonly invoked chronodisruption as a major contributory factor to the reported rise in breast cancer rather than a disturbance or a reduction in the melatonin rhythm [26, 53, 54]. More recently, however, interest in the possible or likely involvement of depressed melatonin levels is attracting greater interest [55, 56]. This surely stems from the experimental studies that document melatonin as a significant endogenous anticancer agent, not only for breast cancer [46, 57, 58] but cancer in general [59–61].
Following the initial observations on breast cancer in females as a consequence of LAN, prostate cancer also began to attract attention. While the studies are not as numerous as those for breast cancer nor is the evidence as provocative, an elevated frequency of prostate cancer may likewise be more frequent in males who experience what would be divergent LD environments [62, 63]. Moreover, it has been speculated that in fact routine perturbations of the LD cycle may be a factor that significantly influences cancer development of many types, not only breast and prostate [59]. Chronodisruption and melatonin suppression as being potentially carcinogenic has even been noted by the World Health Organization, inasmuch as they have classified circadian disturbance as a Group 2A carcinogen; this classification suggests that there is likely (although not definitively proven) a relationship between the elevated frequency of certain cancer types and chronic alterations in the naturally occurring LD cycles [64]. While a considerable amount of data, most of which is observational, suggests that some aspect of circadian disruption contributes to a higher prevalence of certain cancer types, the idea is not enthusiastically supported by some [65]. On the other hand, to assume that routine chronodisruption due to what must be considered abnormal or unusual LD cycles is totally inconsequential in reference to potential pathophysiologies would seem imprudent. Other cancer types that have been tentatively linked to LAN/chronodisruption include endometrial [66], colorectal [67] and lung [68].
If a definitive link between chronic perturbations of the LD cycle and pathologies, i.e., cancer, is established, it will be important to identify the mechanisms involved. With the exposure to light at night, at least three things can happen, i.e., the individual may experience chronodisruption, there may be a reduction in sleep duration or efficiency, and nocturnal melatonin levels may be suppressed (Fig. 4.2). At this point, it is not known which of these contribute to the presumed physiological rearrangements and the alleged pathologies that may occur. Certainly each of these, i.e., chronodisruption, sleep deprivation, and melatonin suppression, may individually be capable of contributing to any pathology that occurs. It would seem what is most likely, however, is that these unusual disturbances conspire to precipitate molecular physiological perturbations at the level of individual cells that then eventually cause overt pathologies.
Interestingly, the changes caused by light exposure at abnormal times, i.e., during darkness, cause functional changes that are reminiscent of those seen in older humans, when pathologies of various types are more likely to be manifested. Thus, aging is associated with changes typical of chronodisruption [1], sleep is often impaired in the elderly [15, 21, 38, 39], and melatonin levels diminish with advanced age [69, 70].
Finally, if cancer, particularly breast cancer, is one manifestation of excessive and chronic exposure to light at night, it would seem likely that this would not be the only pathology that would occur. Indeed, within the last decade many diseases have been at least theoretically related to disturbances of biological rhythmicity, sleep deprivation and less than adequate amounts of sleep [29, 38, 71–73]. Thus, it would seem likely that many pathologies which are common in the aged, may in fact also be aggravated by chronic exposure to excessive light at night (Fig. 4.2).
Chronodisruption, Metabolic Syndrome (MetS), and Obesity
Since the discovery of the CLOCK mutant mice, to the present moment many outstanding and consistent studies have demonstrated the important connection between CD and obesity (Fig. 4.3).
Although the connection between obesity and CD will be treated in several chapters along the present book, it is important to highlight that our experiments in humans are showing that MetS metabolic disturbances such as increased blood pressure, increased glucose and plasma lipids regulation, and changes in adipocyte-secreted hormones such as leptin and adiponectin, associates with diminished daily amplitude in melatonin and cortisol circadian patterns, demonstrated the existence of chronodisruption with metabolic syndrome [74]. In this line, in another experiment also performed by our group, analyses of skin temperature indicated that obese women displayed significantly lower mean wrist temperature (WT) with a more flattened 24-h pattern, a lower-quality rhythm, and a higher intradaily variability. Particularly interesting were the marked differences between obese and normal-weight women in the secondary WT peak in the postprandial period, considered as a marker of chronodisruption and of metabolic alterations. These 24-h changes were associated with higher MetS risk [75].
Other Pathologies Related to CD
While this chapter considered mainly the potential association of chronodisruption with cancer and with obesity, there may well be other health-related problems that occur as a consequence of imposed chronic changes in the LD environment that severely disturb circadian rhythmicity [76].
Multiple records link CD with the increased risk of developing premature aging, cardiovascular diseases, cognitive impairment and mood disorders, among others.
Similar to that observed in many physiological processes, the functioning of the circadian system changes with age. Phase advance, reduced amplitude, circadian fragmentation, impaired ability to resynchronize after a time shift and internal desynchronization among different rhythms are the major characteristics of aged rhythms [77]. However, less well known is the fact that CD has a direct role in inducing accelerated aging [78, 79]. Although it is generally believed that disruptions in circadian rhythms lead to reduced life expectancy, whereas their appropriate resetting leads to well-being and increased longevity [77].
Cardiovascular diseases are also related to chronodisruption. In people with normal blood pressure (BP) and uncomplicated essential hypertension, BP declines to its lowest levels during night-time sleep, rises abruptly with morning awakening and attains a maximum during diurnal activity. It has been shown that night-time BP is the best predictor of stroke and myocardial infarction risk [80, 81]. Thus, hypertensive patients with a normal reduction in nocturnal BP (dipper) had a relative hazard of cardiovascular mortality similar to that in non-dipper normotensives. It is noteworthy that the non-dipper circadian pattern is more frequent among shift workers and elderly people [80, 81].
The circadian system modulates cognition and affective function by projections from SCN to arousal and sleep systems and through eliciting changes in clock genes in extra-SCN brain regions. Chronodisruption in the sleep–wake circadian rhythm has important implications for learning, memory and emotion [82]. When wakefulness occurs at appropriate internal biological times, circadian system benefits human cognitive and emotion function. However, when wakefulness occurs at inappropriate biological times because of social pressures, such as early school start times, work at night, shift work, and jet lag, or because of circadian sleep disorders, the resulting misalignment between circadian and wakefulness–sleep physiology leads to impaired cognitive performance, learning, emotion, and safety [82].
Experimental studies specifically addressing the treatment of chronodisruption are lacking. However, the development of technical improvement in healthy lighting systems and all behavioral and pharmacological treatments that improve the circadian system status (chronoenhancement) may help to reduce the risk of pathologies associated to chronodisruption (Fig. 4.4).
Concluding Remarks
As discussed in this brief review, the misuse of artificial light, i.e., light after darkness onset, causes disintegration of biological clock processes such that the temporal architecture of cells, which is the basis of optimal physiology, breaks down, thereby contributing to pathophysiologies. Additionally, LAN reduces an important chemical messenger from the pineal gland, melatonin, the loss of which likely also contributes to increased pathologies, e.g., cancer, and reduced quality of life. While this brief review considered the potential association of chronodisruption and cancer, there may well be other health-related problems that occur as a consequence of imposed chronic changes in the LD cycle and other non photic synchronizers that severely disturb circadian rhythmicity [76].
Summary Points
-
The suprachiasmatic nucleus conveys circadian information to the peripheral cellular oscillators through both neural and humoral messages. One important humoral message is the melatonin signal from the pineal gland.
-
Melatonin, also known as “chemical darkness,” shows a circadian rhythm which is regulated by a double mechanism: an endogenous pattern driven by the suprachiasmatic nucleus of hypothalamus and an acute inhibitory effect of nocturnal light.
-
The introduction of artificial sources of light roughly 150 years ago has significantly undermined the naturally occurring light–dark cycle and, likewise, has disturbed circadian rhythms since light is now available at unusual times. Light at night is known to cause circadian disruption and melatonin suppression.
-
In our modern society, circadian disruption may be common in several conditions such as jet lag, shift work, light at night, or social jet lag. In addition clock gene polymorphisms and aging may also predispose to chronodisruption.
-
In the recent years chronodisruption is being associated with an impairment of several pathologies such as cancer, cardiovascular diseases, sleep disorders, premature aging, obesity, metabolic syndrome, and cognitive and affective disorders.
Abbreviations
- SCN:
-
Suprachiasmatic nucleus
- CD:
-
Chronodisruption
- LD:
-
Light–dark
- LAN:
-
Light at night
- ACTH:
-
Adrenocorticotropic hormone
- BMAL1 or ARNTL or MOP3:
-
Aryl hydrocarbon receptor nuclear translocator-like
- PER2:
-
Period homolog 2 (Drosophila)
- CLOCK:
-
Circadian locomotor output cycles kaput
- MetS:
-
Metabolic syndrome
- WT:
-
Wrist temperature
- BP:
-
Blood pressure
References
Erren TC, Reiter RJ (2009) Defining chronodisruption. J Pineal Res 46:245–247
Garaulet M, Ordovas JM, Gomez-Abellan F, Martinez JA, Madrid JA (2011) An approximation of the temporal order in endogenous circadian rhythms of genes implicated in human adipose tissue metabolism. J Cell Physiol 226:2075–2080
Hardeland R, Madrid JA, Tan DX, Reiter RJ (2012) Melatonin, the circadian oscillatory system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 52:139–166
Do MT, Yau KW (2010) Intrinsically photosensitive retinal ganglion cells. Physiol Rev 90:1547–1581
Chen SK, Badea TC, Hattar S (2011) Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs. Nature 476:92–95
Sand A, Schmidt TM, Kofuji P (2012) Diverse types of ganglion cell photoreceptors in the mammalian retina. Prog Retin Eye Res 31(4):287–302
Stehle JH, Saade A, Rawashdeh O, Akermann K, Jilg A, Sebesteny T, Maronde E (2011) A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 51:17–43
Panke ES, Rollag MD, Reiter RJ (1980) Effects of photoperiod on hamster pineal melatonin concentrations. Comp Biochem Physiol 66A:691–693
Vaughan GM, Pelham RW, Pang SF, Laughlin LL, Wilson KW, Sandock KL, Vaughan MK, Koslaw SH, Reiter RJ (1976) Nocturnal elevation of plasma melatonin and urinary 5-hydroxyindoleacetic acid in young men: attempts at modification by brief changes in environmental lighting and sleep and by autonomic drugs. J Clin Endocrinol Metab 42:752–764
Jung-Hynes B, Reiter RJ, Ahmad N (2010) Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 48:9–19
Garaulet M, Ordovás JM, Madrid JA (2010) The chronobiology, etiology and pathophysiology of obesity. Int J Obes (Lond) 34(12):1667–1683, Epub 2010 Jun 22. Review
Reiter RJ, Paredes SD, Manchester LC, Tan DX (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44:175–200
Martinez-Nicolas A, Ortiz-Tudela E, Madrid JA, Rol MA (2011) Cross talk between environmental light and internal time in humans. Chronobiol Int 28:617–629
Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP (1980) Light suppresses melatonin secretion in humans. Science 201:1267–1269
Brainard GC, Richardson BA, Petterbarg LJ, Reiter RJ (1982) The effect of different light intensities on pineal melatonin content. Brain Res 233:75–81
Brainard GC, Richardson BA, King TS, Matthews SA, Reiter RJ (1983) The suppression of pineal melatonin content and N-acetyltransferace activity by different light irradiances: a dose–response relationship. Endocrinology 113:293–296
Brainard GC, Richardson BA, Hurlbut EC, Steinlechner S, Matthews SA, Reiter RJ (1984) The influence of various irradiances of artificial light, twilight and moonlight on the suppression of pineal melatonin content in the Syrian hamster. J Pineal Res 1:105–119
Brainard GC, Richardson BA, King TS, Reiter RJ (1984) The influence of different light spectra in the suppression of pineal melatonin content in the Syrian hamster. Brain Res 294:333–339
Wehr TA (1991) The duration of human melatonin secretion and sleep respond to changes in daylength (photoperiod). J Clin Endocrinol Metab 73:1276–1280
Bass J, Turek FW (2005) Sleepless in America: a pathway to obesity and metabolic syndrome. Arch Intern Med 165:15–16
Reiter RJ, Tan DX, Erren TC, Fuentes-Broto L, Paredes SD (2009) Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther 8:354–360
Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1:57–60
Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, Lynch DT, Rollag MD, Zalatan F (2005) Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65:11174–11184
Reiter RJ, Tan DX, Fuentes-Broto L (2010) Melatonin: a multi-tasking molecule. Prog Brain Res 181:127–151
Galano A, Tan DX, Reiter RJ (2011) Melatonin as a natural ally against oxidative stress: a physiochemical examination. J Pineal Res 51:1–16
Hanson J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77
Erren TC, Pepe HG, Reiter RJ, Prekarski C (2008) Chronodisruption and cancer. Naturwissenschaften 95:367–382
Alvarez-Garcia V, Gonzalez A, Alonso-Gonzalez C, Martinez-Campa C, Cos S (2012) Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production. J Pineal Res 52:292–290
Turek FW, Joshu C, Kahsaka A, Lin E, Ivanova G, McDeamon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J (2005) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308:1043–1045
Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, Manchester LC (2007) Light-at-night, chronodisruption, melatonin suppression and cancer risk: a review. Crit Rev Oncog 13:303–328
Mediavilla MD, Sanchez-Barcelo E, Tan DX, Manchester LC, Reiter RJ (2010) Basic mechanism involved in the anti-cancer actions of melatonin. Curr Med Chem 17:4462–4481
Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E, Sauer LA (2011) Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res 51:259–269
Van Cauter E, Spiegel K, Tasali E, Leproult R (2008) Metabolic consequences of sleep and sleep loss. Sleep Med 9(Suppl 1):S23–S28
National Center for Health Statistics (2000) Quick stats: percentage of adults who report an average of 6 hours of sleep per 24-hour period by sex and age group United States, 1985–2004. Biol Psychiatr 47:921–927
Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, Kaprio J (2005) Sleep duration and breast cancer: a prospective cohort study. Cancer Res 65:9595–9606
Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB (2006) A prospective study of habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 66:5521–5525
Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Wu MC (2008) Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 29:1244–1248
Blask DE (2009) Melatonin, sleep disturbances and cancer risk. Sleep Med Rev 13:357–364
Hill SM, Frasch T, Xiang S, Yuan I, Duplessis T, Mao L (2009) Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 8:301–308
Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M (2001) Entrainment of the circadian clock in the liver by feeding. Science 291:490–493
Qin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T (2003) The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci 73:2467–2475
Scheer FA, Hilton MF, Mantzoros CS, Shea SA (2009) Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A 106:4453–4458
Bechtold DA, Gibbs JE, Loudon AS (2010) Circadian dysfunction in disease. Trends Pharmacol Sci 31:191–198
Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev 20:1868–1873
Fu L, Pelicano H, Liu J, Huang P, Lee C (2002) The circadian gene Period 2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50
Filipski E, Dalauney F, King VM (2004) Effects of chronic jet lag in tumor progression in mice. Cancer Res 64:7879–7985
Filipski E, Li XM (2006) Disruption of circadian coordination and tumor progression in mice. Cancer Causes Control 17:509–514
Rosbach M, Takahachi JS (2002) The cancer connection. Nature 420:373–374
Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12:95–101
Kojo K, Pukkala F, Auvinen A (2005) Breast cancer risk among Finnish cabin attendants: a nested case–control study. Occup Environ Med 62:488–493
Megdal SP, Kroenke CN, Laden F, Pukkala E, Schernhammer ES (2005) Night shift work and breast cancer: a systematic review and meta-analysis. Eur J Cancer 41:2023–2032
Stevens RG (2005) Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 16:254–258
Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night and risk of breast cancer. J Natl Cancer Inst 93:1557–1562
Kolstad HA (2008) Shift work and the risk of breast cancer and other cancers – a critical review of the epidemiologic evidence. Scand J Work Environ Health 34:5–22
Viswanathan AN, Schernhammer ES (2009) Circulating melatonin and the risk of breast and endometrial cancer in women. Cancer Lett 28:1–7
Davis S, Mirick DK, Chen C, Stanczyk FZ (2012) Night shift work and hormone levels in women. Cancer Epidemiol Biomarkers Prev 21:609–618
Lee SE, Kim SJ, Youn JP, Hwang SY, Park CS, Park YS (2011) MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect. J Pineal Res 51:345–352
Proietti S, Cucina A, D’Anselmi F, Dinicola S, Pasqualato A, Lisi E, Bizzari M (2011) Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal Res 50:150–158
Erren TC, Reiter RJ (2008) A generalized theory of carcinogenesis due to chronodisruption. Neuro Endocrinol Lett 29:815–821
Carbajo-Pescador S, Garcia-Palomo A, Martin-Renedo J, Piva M, Gonzalez-Gallego J, Mauriz JL (2011) Melatonin modulation of intracellular-signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor. J Pineal Res 51:463–471
Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, Lee EO, Kim SH (2001) Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res 51:87–93
Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, Miki T, Nakao M, Hayaski K, Suzuki K, Mori M, Washio M, Sakauchi F, Ito Y, Yoshimura T, Tamakoshi A (2006) Prospective cohort study of the risk of prostate cancer among rotating shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164:549–555
Costa G, Haus E, Stevens R (2010) Shift work and cancer—consideration on rationale, mechanisms, and epidemiology. Scand J Work Environ Health 36:163–179
Straif K, Baan R, Grosse Y, Secretan B, El-Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V (2007) Carcinogenicity of shift work, painting and fire-fighting. Lancet Oncol 8:1065–1066
Kantermann T, Roenneberg T (2009) Is light-at-night a health risk factor or health risk predictor? Chronobiol Int 6:1069–1074
Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW (2012) Sleep duration and endometrial cancer risk. Cancer Causes Control 23:547–553
Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA (2003) Night-shift work and risk of colorectal cancer in the nurse’ health study. J Natl Cancer Inst 95:825–828
Logan RW, Zhang C, Murugan S, O’Connell S, Levitt D, Rosenwasser AM, Sarkar DK (2012) Chronic shift-lag alters the circadian clock of NK cells and promotes lung cancer growth in rats. J Immunol 188:2583–2591
Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM (1986) Human melatonin production decreases with age. J Pineal Res 3:379–388
Reiter RJ, Richardson BA, Johnson LY, Ferguson BN, Dinh DT (1980) Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 210:1372–1373
Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ (2011) Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 12:167–188
Tan CW, Shiu SYW (2011) Functional interplay between melatonin-receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer. J Pineal Res 51:297–312
Reiter RJ, Tan DX, Korkmaz A, Ma S (2012) Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med 44:564–577
Corbalan-Tutau MD, Madrid JA, Nicolas F, Garaulet M (2012) Daily profile in two circadian markers “melatonin and cortisol” and associations with Metabolic Syndrome components. Physiol Behav. Jun 13 [Epub ahead of print]
Corbalán-Tutau MD, Madrid JA, Ordovás JM, Smith CE, Nicolás F, Garaulet M (2011) Differences in daily rhythms of wrist temperature between obese and normal-weight women: associations with metabolic syndrome features. Chronobiol Int 28:425–433
Flo E, Pallesen S, Mageroy N, Moen BE, Gronli J, Nordhus IH, Bjorvatn B (2012) Shift work disorders in nurses—assessment, prevalence and related health problems. PLoS One 7:e33981
Hofman MA, Swaab DF (2006) Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 5:33–51
Davidson AJ, Sellix MT, Daniel J, Yamazaki S, Menaker M, Block GD (2006) Chronic jet-lag increases mortality in aged mice. Curr Biol 16:R914–R916
Hurd MW, Ralph MR (1998) The significance of circadian organization for longevity in the golden hamster. J Biol Rhythms 13:430–436
Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O’Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350:757–764
Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y (2002) Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 20:2183–2189
Wright KP, Lowry CA, Lebourgeois MK (2012) Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 5:50, Epub 2012 Apr 18
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Reiter, R.J., Liu, X., Manchester, L.C., Rosales-Corral, S.A., Tan, DX., Pérez, J.A.M. (2013). Processes Underlying Chronodisruption and Their Proposed Association with Illness. In: Garaulet, M., Ordovás, J. (eds) Chronobiology and Obesity. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5082-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5082-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5081-8
Online ISBN: 978-1-4614-5082-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)